Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.
2.

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.

Vrieling A, Buck K, Kaaks R, Chang-Claude J.

Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Review.

PMID:
20711809
3.

Breast lesions in black women.

Kovi J, Mohla S, Norris HJ, Sampson CC, Heshmat MY.

Pathol Annu. 1989;24 Pt 1:199-218. Review.

PMID:
2654837
4.

Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1558-68. Review.

5.
7.

[Steroid receptors and breast carcinoma].

Pasić R, Dulbegović B, Softić D, Wittlif JL.

Med Pregl. 1991;44(1-2):48-51. Review. Croatian.

PMID:
1870463
8.

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.

Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN.

J Clin Oncol. 2006 May 1;24(13):2113-22. Review.

PMID:
16648513
9.

[Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].

Nizze H, al-Thobhani AK, Terpe H.

Zentralbl Chir. 1998;123 Suppl 5:14-8. Review. German.

PMID:
10063564
10.

The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Vihko R, Alanko A, Isomaa V, Kauppila A.

Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. Review.

PMID:
3543533
11.

Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer.

Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R.

Semin Oncol. 2010 Aug;37(4):384-401. doi: 10.1053/j.seminoncol.2010.05.002. Review.

PMID:
20816508
12.

[Hormone receptors and breast cancer prognosis].

Saez S, Pichon MF.

Pathol Biol (Paris). 1983 Dec;31(10):801-8. Review. French.

PMID:
6366701
13.
14.

Steroid hormone receptors in breast cancer management.

Osborne CK.

Breast Cancer Res Treat. 1998;51(3):227-38. Review.

PMID:
10068081
15.

HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.

Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC.

Anticancer Res. 2005 Jul-Aug;25(4):2921-7. Review.

16.

A meta-analysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer.

Chen Y, Yan J, Yuan Z, Yu S, Yang C, Wang Z, Zheng Q.

Bull Cancer. 2013 Mar;100(3):1-10. doi: 10.1684/bdc.2013.1719. Review.

PMID:
23501839
17.

11. Breast cancer in young women.

Kothari AS, Fentiman IS.

Int J Clin Pract. 2002 Apr;56(3):184-7. Review.

PMID:
12018823
18.

Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis.

Li S, Yang X, Zhang Y, Fan L, Zhang F, Chen L, Zhou Y, Chen X, Jiang J.

Breast Cancer Res Treat. 2012 Sep;135(2):325-34. doi: 10.1007/s10549-012-2063-z. Epub 2012 Apr 22. Review.

PMID:
22527109
19.

Breast cancer in men.

Giordano SH, Buzdar AU, Hortobagyi GN.

Ann Intern Med. 2002 Oct 15;137(8):678-87. Review.

PMID:
12379069
20.

Breast cancer in African-American women: differences in tumor biology from European-American women.

Amend K, Hicks D, Ambrosone CB.

Cancer Res. 2006 Sep 1;66(17):8327-30. Review.

Supplemental Content

Support Center